Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Treatment for Erectile Dysfunction in Male Multiple Sclerosis Patients
NCT04601233Phase 4Withdrawn
- Sponsor
- Tulane University
- Start
- Jun 2026
- Primary completion
- Sep 2026
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of testosterone undecanoate in erectile dysfunction (ED), testosterone deficiency (TD), sponsored by Tulane University. Planned start Jun 2026; status: withdrawn.
02
Drugs
testosterone undecanoate
03
Conditions
erectile dysfunction (ED)testosterone deficiency (TD)
Beyond the preview
Go deeper on NCT04601233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04601233.